ClinicalTrials.gg
Enrolling by invitationNCT07590882PAO-RUpdated May 15, 2026

Evaluation of Return to Sports Activity After Periacetabular Osteotomy: An Observational Study

An observational study in Hip Surgeries and Hip Developmental Dysplasia, sponsored by Istituto Ortopedico Rizzoli. Enrolling by invitation at 1 site in Italy. Open to participants aged 12 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-05-15.

Sponsored by Istituto Ortopedico Rizzoli · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
26
Ages
12 Years to 40 Years
Sex
All
01

Study summary

This study aims to collect datas about patient who underwent periacetabular osteotomy

Read the detailed description

The aim of the study is to understant the long term effet of the periacetabular osteotomy in terms of pain relief, patient satisfaction and ability to return to sports

02

Conditions studied

  • Hip Surgeries
  • Hip Developmental Dysplasia
03

In context

Developmental Dysplasia of the Hip

60 studies on the registry are indexed under Developmental Dysplasia of the Hip; 18 are open to participants now.

This study's planned enrollment of 26 is below the median of 72 across 21 observational studies indexed under Developmental Dysplasia of the Hip.

Browse Developmental Dysplasia of the Hip studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 304 studies on the registry; 103 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients undergoing periacetabular osteotomy

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients of both sexes who underwent periacetabular osteotomy (PAO) at the sites of the Istituto Ortopedico Rizzoli (IOR) in Bologna (CORTI), Argenta, and Bagheria between 2017 and March 2025
  • Postoperative follow-up ≥ 6 months
  • Complete clinical and radiographic documentation available for retrospective analysis
  • Willingness to participate in the study
  • Age at the time of surgery between 12 and 40 years

Exclusion criteria

Exclusion Criteria:

  • Patients unable to provide , unable to understand and decide, or minors whose parents/legal guardians do not provide informed consent
  • Patients with previous or ongoing oncological diseases, if associated with a potential impact on joint function or bone healing
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
26 participants (estimated)
Patient registry
No

Groups and cohorts

  • patient undergoing periacetabular osteootmy

    patient undergoing periacetabular osteootmy

    Procedure: Correction Factor

Interventions

  • ProcedureCorrection Factor

    periacetabular osteotomy

06

What researchers measure

Primary outcomes

  1. return to sport

    The percentage of patients who return to their preoperative sports activity

    Time frame: follow-up of 6 months

Secondary outcomes

  1. failure rate

    determine the failure rate of PAO during follow-up

    Time frame: follow-up of 6 months

  2. level of pain post operative

    Pain assessment using the Visual Analog Scale (VAS)

    Time frame: follow-up of 6 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07590882
Responsible party
Sponsor
First posted
May 15, 2026
Start date
Nov 4, 2025
Primary completion
Jan 1, 2027 (estimated)
Completion
Jan 1, 2027 (estimated)
Last update
May 15, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion